Gilead Sciences Inc (NASDAQ: GILD)
DRUGS - Biotechnology
Health Care
Stock price data as of
Closing price: $117.18
-
Support level$109.57
-
Resistance level$118.57
-
Beta0.3
-
RSI (14-day)62.4
- GILD is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- Up 4.0 percent, GILD is one of this week's biggest gainers.
- Volatility is forecast to fall over the next month.
- Price crossed above 50-day moving average this week - a bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $84.95 | $120.47 | 92.1% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $107.71 | $114.65 | $113.38 | $114.06 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week6.3%
-
In the next month13.2%
-
In the next year52.3%
| Period | Value |
|---|---|
| Historical (5 year) | 23.3% |
| Last month | 24.7% |
| Current estimate | 23.0% |
| Next month forecast | 23.4% |